This topic contains a solution. Click here to go to the answer

Author Question: Caffeine has been shown to be an effective treatment for A. migraine headaches. B. anxiety. C. ... (Read 49 times)

pepyto

  • Hero Member
  • *****
  • Posts: 547
Caffeine has been shown to be an effective treatment for
 
  A. migraine headaches.
  B. anxiety.
  C. narcolepsy.
  D. panic disorder.

Question 2

One important determinant of the behavioral effects of caffeine is
 
  A. whether it is consumed in a pill or as coffee.
  B. whether the person is a regular user.
  C. the temperature of the beverage (hot or cold).
  D. the acidity of the coffee.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lorealeza77

  • Sr. Member
  • ****
  • Posts: 356
Answer to Question 1

A

Answer to Question 2

B




pepyto

  • Member
  • Posts: 547
Reply 2 on: Jun 22, 2018
Great answer, keep it coming :)


FergA

  • Member
  • Posts: 352
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Atropine, along with scopolamine and hyoscyamine, is found in the Datura stramonium plant, which gives hallucinogenic effects and is also known as locoweed.

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

Prostaglandins were first isolated from human semen in Sweden in the 1930s. They were so named because the researcher thought that they came from the prostate gland. In fact, prostaglandins exist and are synthesized in almost every cell of the body.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library